Why the study?
Does low-dose captopril improve clinical status and physiological parameters in patients with severe congestive heart failure refractory to conventional treatment?
Does low-dose captopril improve clinical status and physiological parameters in patients with severe congestive heart failure refractory to conventional treatment?
Low-dose captopril provides significant clinical and hemodynamic improvement in patients with severe congestive heart failure refractory to conventional diuretic and digitalis therapy.
No takes yet. Share an insight, caveat, or question.
May benefit refractory HF patients; hypothesis-generating observational data requiring RCTs before practice change.
Dahlström et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: